SCHEMBL5541518

SCHEMBL5541518

CC(C)C(C)(C)C(=O)NCC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
PTGS2 P35354 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ECE1 P42892 1/20 0.41
MME P08473 2/20 0.40
ACE P12821 2/20 0.40
CPA1 P15085 1/20 0.40
ACE2 Q9BYF1 1/20 0.40
EGLN1 Q9GZT9 2/20 0.39
CTH P32929 1/20 0.35
APEX1 P27695 1/20 0.34
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
FPR2 P25090 1/20 0.33
OPRK1 P41145 1/20 0.33
PLA2G2A P14555 1/20 0.32
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10266048 0.81 TET2 (0.47) ALDH1A1LMNACYP2C19
SCHEMBL5541412 0.79 PIK3CD (0.33) ALDH1A1LMNAOPRK1
SCHEMBL18907822 0.77 MMP8 (0.34) ALDH1A1CYP2D6CYP2C19OPRK1
SCHEMBL1650978 0.77 EGLN1 (0.44) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL18909748 0.76 CYP2D6 (0.50) ALDH1A1MAPTCYP2D6CYP2C19
SCHEMBL9775242 0.75 ALDH1A1 (0.44) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL5542596 0.75 LMNA (0.36) LMNA
SCHEMBL8787301 0.75 EGLN1 (0.43) ALDH1A1LMNAMAPTPTGS2TDP1
Ammonia Solution, Strong SCHEMBL27685625 0.75 EGLN1 (0.43) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL14108227 0.74 ALDH1A1 (0.41) ALDH1A1MAPTTDP1CYP2C19OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200102331-A1 PENICILLIN-BINDING PROTEIN INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-04-02 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200102331-A1 PENICILLIN-BINDING PROTEIN INHIBITORS PEPD, BPGM, EBPL ALDH1A1 2794/4885LMNA 3468/4885MAPT 3146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.